Catalyst Wire Dossier Catalyst Wire Dossier

Zodasiran

· Arrowhead Pharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Zodasiran, covering 2026-03-20 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE) [Phase 3]

See pricing